 0 Table of Contents |
  1 Home |
  2 Actors |
  3 Changes |
  4 Copyrights |
  5 Data Types Defined in This Guide |
  6 Design Conventions |
  7 Downloads |
  8 Empty Sections and Missing Data |
  9 Examples |
  10 General Principles |
  11 Generation and Data Inclusion |
  12 IG Analysis |
  13 Known Issues and Future Development |
  14 Must Support and Obligations |
  15 Privacy and Security Considerations |
  16 Profiles |
  17 Structure of the International Patient Summary |
  18 Terminology |
  19 Artifacts Summary |
   19.1 Consumer (IPS) |
   19.2 Creator (IPS) |
   19.3 Server (IPS) |
   19.4 IPS Server Capability Statement |
   19.5 IPS Summary |
   19.6 Document |
   19.7 DocumentSection |
   19.8 International Patient Summary Sections - Logical Model |
   19.9 AllergyIntolerance (IPS) |
   19.10 Bundle (IPS) |
   19.11 Composition (IPS) |
   19.12 Condition (IPS) |
   19.13 Device (IPS) |
   19.14 Device - Performer or Observer (IPS) |
   19.15 DeviceUseStatement (IPS) |
   19.16 DiagnosticReport (IPS) |
   19.17 Flag - Alert (IPS) |
   19.18 ImagingStudy (IPS) |
   19.19 Immunization (IPS) |
   19.20 Medication (IPS) |
   19.21 MedicationRequest (IPS) |
   19.22 MedicationStatement (IPS) |
   19.23 Observation Pregnancy - Expected Delivery Date (IPS) |
   19.24 Observation Pregnancy - Outcome (IPS) |
   19.25 Observation Pregnancy - Status (IPS) |
   19.26 Observation Results - Laboratory/Pathology (IPS) |
   19.27 Observation Results - Radiology (IPS) |
   19.28 Observation Social History - Alcohol Use (IPS) |
   19.29 Observation Social History - Tobacco Use (IPS) |
   19.30 Organization (IPS) |
   19.31 Patient (IPS) |
   19.32 Practitioner (IPS) |
   19.33 PractitionerRole (IPS) |
   19.34 Procedure (IPS) |
   19.35 Specimen (IPS) |
   19.36 Codeable Concept (IPS) |
   19.37 Coding with translations |
   19.38 Allergies & Intolerances - IPS |
   19.39 Allergy Reaction - IPS |
   19.40 Body Site - IPS |
   19.41 Current Smoking Status - IPS |
   19.42 Diagnostics Report Status Codes - IPS |
   19.43 Healthcare Professional Roles - IPS |
   19.44 Imaging Study Status Codes - IPS |
   19.45 Medical Devices - IPS |
   19.46 Medications - example (IPS) |
   19.47 Medications - IPS |
   19.48 Medicine Active Substances - IPS |
   19.49 Medicine EDQM Doseform - IPS |
   19.50 Medicine EDQM Route of Administration - IPS |
   19.51 Personal Relationship - IPS [Deprecated] |
   19.52 Pregnancy Expected Delivery Date Method - IPS |
   19.53 Pregnancy Outcome - IPS |
   19.54 Pregnancy Status - IPS |
   19.55 Problem Type (LOINC) |
   19.56 Problem Type - IPS |
   19.57 Problems - IPS |
   19.58 Procedures - IPS |
   19.59 Results Blood Group - IPS |
   19.60 Results Coded Values Laboratory/Pathology - IPS |
   19.61 Results Laboratory/Pathology Observation - IPS |
   19.62 Results Microorganism - IPS |
   19.63 Results Pathology - IPS |
   19.64 Results Presence/Absence - IPS |
   19.65 Results Radiology Component - IPS |
   19.66 Results Radiology Observation - IPS |
   19.67 Results Specimen Collection Method - IPS |
   19.68 Results Specimen Type - IPS |
   19.69 Results Status Codes - IPS |
   19.70 Vaccine Target Diseases - IPS |
   19.71 Vaccines - IPS |
   19.72 Vaccines WHO ATC - IPS |
   19.73 WHO ATC - IPS |
   19.74 AllergyIntolerance - Multiple Codings |
   19.75 AllergyIntolerance - No Known Allergies |
   19.76 AllergyIntolerance - Resolved Allergy |
   19.77 Bundle - IPS with All Sections |
   19.78 Bundle - IPS with Data |
   19.79 Bundle - IPS with Required Sections and Immunization |
   19.80 Bundle - Minimal Complete IPS |
   19.81 Bundle - No Information in Required Sections |
   19.82 Composition - Minimal Sections |
   19.83 Condition - Acute Myeloid Leukemia |
   19.84 Device - Device Observer |
   19.85 Device - No Known Devices in Use |
   19.86 DeviceUseStatement - No Known Devices in Use |
   19.87 DiagnosticReport - Hemoglobin |
   19.88 Flag - Alert of Patient Immunocompromised |
   19.89 ImagingStudy - Referred DICOM Study |
   19.90 Immunization - Vaccin anti diphtérie-coqueluche-tétanos-poliomyélite (Luxembourg) |
   19.91 Medication - Simvastatin 40 MG Disintegrating Oral Tablet |
   19.92 MedicationRequest - Simvastatin Request |
   19.93 MedicationStatement - Ongoing Simvastatin Treatment |
   19.94 Observation - Social History Alcohol Use |
   19.95 Observation: estrogen receptor in tissue example |
   19.96 Observation: hemoglobin example |
   19.97 Observation: imaging Chest X-ray - PA and lateral, with additional sub-observation including numeric range |
   19.98 Observation: imaging CT Abdomen W contrast IV |
   19.99 Observation: imaging CT Abdomen W contrast IV, sub-observations |
   19.100 Observation: pathology suppressed example |
   19.101 Observation: pregnancy edd example |
   19.102 Observation: pregnancy outcome example |
   19.103 Observation: pregnancy status example |
   19.104 Observation: serum creatinine example |
   19.105 Observation: SH tobacco use example |
   19.106 Observation: urine wbc range example |
   19.107 Organization - Minimal Name Only |
   19.108 Organization: example |
   19.109 Organization: lab example |
   19.110 Patient: female patient |
   19.111 Patient: male patient |
   19.112 Patient: minimal example |
   19.113 Practitioner example |
   19.114 PractitionerRole - Minimal |
   19.115 Procedure: Missing Data |
   19.116 Procedure: Surgical procedure |
   19.117 Specimen: example |